Location History:
- Chicago, IL (US) (2007 - 2011)
- Edmond, OK (US) (2008 - 2012)
Company Filing History:
4 out of 7 
4 out of 2,345 
2 out of 197 
Years Active: 2007-2012
Title: Geoffrey M Bilcer: Innovator in Pharmaceutical Chemistry
Introduction
Geoffrey M Bilcer is a notable inventor based in Edmond, OK (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of six patents, showcasing his innovative approach to developing therapeutic agents.
Latest Patents
Among his latest patents, Bilcer has developed (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating Alzheimer's disease. This invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating Alzheimer's disease. Additionally, he has worked on HIV protease inhibitors, which are compounds useful for inhibiting HIV protease. These patents disclose methods of making the compounds and their use as therapeutic agents, particularly in treating wild-type HIV and multidrug-resistant strains of HIV.
Career Highlights
Bilcer has had a significant impact in the field of pharmaceutical research, contributing to advancements that address critical health issues. His work has been instrumental in developing new treatments for diseases that affect millions of people worldwide.
Collaborations
Throughout his career, Bilcer has collaborated with esteemed colleagues, including Arun K Ghosh and Thippeswamy Devasamudram. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.
Conclusion
Geoffrey M Bilcer's work exemplifies the spirit of innovation in pharmaceutical chemistry, with his patents paving the way for new treatments for Alzheimer's disease and HIV. His contributions continue to influence the field and improve patient outcomes.